Rayzebio, Inc IPOs Tomorrow, Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
RayzeBio, Inc (NASDAQ:RYZB) is set to IPO on September 15 on the NASDAQ exchange under the ticker RYZB. The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 13, 2024. RayzeBio is a vertically integrated radiopharmaceutical therapeutics company with a lead program in a Phase 3 clinical trial.
September 14, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RayzeBio's IPO could potentially attract investors interested in the pharmaceutical sector. The insider lock-up period of 180 days may also influence the stock's short-term performance.
IPOs often attract investor attention and can lead to increased trading volume and price volatility. The insider lock-up period could also influence the stock's performance as insiders are not allowed to sell their shares during this period, potentially reducing selling pressure on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100